Article
The prevalence of CHD7 missense versus truncating mutations is higher in patients with Kallmann syndrome than in typical CHARGE patients.
The Journal of clinical endocrinology and metabolism - 1 Oct 2014
Marcos Séverine, Sarfati Julie, Leroy Chrystel, Fouveaut Corinne, Parent Philippe, Metz Chantal, Wolczynski Slawomir, Gérard Marion, Bieth Eric, Kurtz François, Verier-Mine Odile, Perrin Laurence, Archambeaud Françoise, Cabrol Sylvie, Rodien Patrice, Hove Hanne, Prescott Trine, Lacombe Didier, Christin-Maitre Sophie, Touraine Philippe, Hieronimus Sylvie, Dewailly Didier, Young Jacques, Pugeat Michel, Hardelin Jean-Pierre, Dodé Catherine
Abstract excerpt
CONTEXT: Mutations in CHD7, a gene previously implicated in CHARGE (coloboma, heart defect, choanal atresia, retardation of growth and/or development, genital hypoplasia, ear anomalies) syndrome, have been reported in patients presenting with Kallmann syndrome (KS) or congenital hypogonadotropic hypogonadism (CHH). Most mutations causing CHARGE syndrome result in premature stop codons and occur de novo, but the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
